1. Biotech IPO bonanza: Legend Biotech, Forma Therapeutics, Repare — COVID-19 could slow progress in reducing cancer death, NCI warns — ASCO 2020 news from Merck, AstraZeneca, Pfizer, more — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Who are these guys?

Discussion in 'Eurofins' started by Labguy, Nov 21, 2017 at 9:37 AM.

  1. Labguy

    Labguy new user

    Nov 20, 2017
    Likes Received:
    This Belgian company now owns ca. 14 labs across the US including vet labs, environmental and medical labs including a molecular and virological labs. Anyone know much about them, their plan and their management structure?
  2. anonymous

    anonymous Guest

    Their plan is to buy US lab companies, and then get “involved”. Emory Genetics, Viracor, Boston Heart. Squeezing the life out of all of them. Better hope they don’t buy your company. Bunch of idiots.
  3. anonymous

    anonymous Guest

    tbe dutch are cut throat.. i have worked in one of their largest/most successful global labs.. their strategy is to get you to close business- then they lay you off before you get commission owed. This strategy allows them to hire new people, get their business/contacts and repeat the cycle. Very disorganized company
  4. anonymous

    anonymous Guest

    Soulless company. The above named CLIA labs appear to operate independent, but don’t.

    Many functions centralized but disconnected from the end user (be it clinician or employee). Eurofins Executive Management based in US (Matt, Dirk, others scattered) are disconnected from business. The local “presidents” are general managers with operating efficiency concerns - not growth oriented concerns or incentives at all.

    You will never hear “People are Important”.

    Don’t expect options to be granted or paid. Long vesting.

    Don’t expect bonuses - as they are ‘discretionary’.

    If you are being bought by them, expect the post deal lawyers to screw you on milestone payments. Don’t believe the independence that you will be assured.